Insecticides India reports strong H1, resilient Q2 performance

Insecticides (India) Limited (IIL) reported a 2% increase in revenue from operations, reaching Rs. 638 crores for Q2 FY'26, up from Rs. 627 crores year-on-year. Gross profit saw an 11% growth to Rs. 220 crores from Rs. 199 crores, primarily driven by sales of Maharatna products and improved generic profit. EBITDA remained stable at Rs. 89 crores, while PAT slightly decreased to Rs. 59 crores from Rs. 61 crores, attributed to financial costs amid tough market conditions and slower debtor recovery.

During H1 FY'26, IIL maintained an EBITDA margin of 13% and launched five new products, including Altair and Sparcle, to strengthen its core portfolio and address brown plant hopper and improve rice yield. The company focused on expanding its distribution network, enhancing farmer engagement, and advancing its R&D pipeline with new combination molecules and technical collaborations.

Despite a challenging monsoon season that led to a Rs. 150 crores increase in goods returns, the company remains optimistic for H2, anticipating recovery supported by adequate soil moisture for the rabi season and stable input costs. IIL aims for double-digit growth in its Focus Maharatna and Maharatna segments and is targeting Rs. 100 crore contribution from Kaeros in FY'26.